IP Library Assignment 069719/0380
Patent Assignment
Reel/Frame 069719/0380

Assignment of Assignor's Interest

Recorded: 2025-01-02 Pages: 4
Assignors
SCHWARZ, ALEXANDER
Executed: 2022-03-17
NICHOLS, DAVID E.
Executed: 2022-03-20
Assignee
ELEUSIS THERAPEUTICS US, INC.
99 WALL STREET, #2205, NEW YORK, NEW YORK, 10005
Covered Property (1)
Psilocin Benzoate Formulation for Intravenous Infusion
Application: 18/728,208 →
Publication: US 2025/0073207
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 2, 2025
From: WOMBWELL, CLAIRE
To: MACFARLAN SMITH LIMITED
Reel/Frame 069719/0189 →
Assignment of Assignor's Interest Jan 2, 2025
From: FLEET, DAVID ANTHONY
To: QUOTIENT SCIENCES (ALNWICK) LIMITED
Reel/Frame 069719/0347 →
Assignment of Assignor's Interest Jan 2, 2025
From: QUOTIENT SCIENCES (ALNWICK) LIMITED
To: ELEUSIS THERAPEUTICS US, INC.
Reel/Frame 069719/0422 →
Assignment of Assignor's Interest Jan 2, 2025
From: MACFARLAN SMITH LIMITED
To: ELEUSIS THERAPEUTICS US, INC.
Reel/Frame 069809/0088 →